-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
-
Summary
-
Oyster Point Pharma, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q3 2018 to Q3 2022.
- Oyster Point Pharma, Inc. Share-based Payment Arrangement, Expense for the quarter ending September 30, 2022 was $3.77M, a 21% increase year-over-year.
- Oyster Point Pharma, Inc. Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2022 was $15.4M, a 39.7% increase year-over-year.
- Oyster Point Pharma, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $11.9M, a 71.3% increase from 2020.
- Oyster Point Pharma, Inc. annual Share-based Payment Arrangement, Expense for 2020 was $6.97M, a 114% increase from 2019.
- Oyster Point Pharma, Inc. annual Share-based Payment Arrangement, Expense for 2019 was $3.27M, a 2021% increase from 2018.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)